We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

353 hedge funds and large institutions have $5.72B invested in Ionis Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 112 increasing their positions, 119 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 43

4% more funds holding

Funds holding: 339 → 353 (+14)

6% less repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 119

11% less capital invested

Capital invested by funds: $6.45B → $5.72B (-$735M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

35% less call options, than puts

Call options by funds: $78.8M | Put options by funds: $120M

Holders
353
Holders Change
+14
Holders Change %
+4.13%
% of All Funds
9.51%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
58
Increased
112
Reduced
119
Closed
43
Calls
$78.8M
Puts
$120M
Net Calls
-$41.7M
Net Calls Change
-$37.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$36.1M
2
CS
Credit Suisse
Switzerland
+$30.3M
3
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
+$29.1M
4
First Trust Advisors
First Trust Advisors
Illinois
+$25M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$24.7M

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$126M
2
BA
BlackRock Advisors
Delaware
-$50.1M
3
EAM
Eagle Asset Management
Florida
-$46.5M
4
State Street
State Street
Massachusetts
-$42.6M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$42.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Twin Tree Management
301
Twin Tree Management
Texas
$38K +$41.5K +652 New
KPCM
302
Kings Point Capital Management
New York
$37K – – –
WEC
303
Winslow Evans & Crocker
Massachusetts
$31.1K +$2.54K +40 +8%
NFG
304
Next Financial Group
Texas
$31K – – –
RFA
305
Reilly Financial Advisors
California
$31K +$1.59K +25 +5%
JFGIW
306
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$29K – – –
PSUF
307
People's United Financial
Connecticut
$29K – – –
HCMT
308
Highland Capital Management (Tennessee)
Tennessee
$29K +$31.8K +500 New
RIA
309
Regal Investment Advisors
Michigan
$28K – – –
MFS
310
MSI Financial Services
Massachusetts
$28K +$14K +220 +81%
TDC
311
Thompson Davis & Co
Virginia
$26K – – –
Northwestern Mutual Wealth Management
312
Northwestern Mutual Wealth Management
Wisconsin
$22K +$15.1K +238 +165%
BRWM
313
B. Riley Wealth Management
Tennessee
$21K – – –
SAMC
314
Shinko Asset Management Company
Japan
$21K – – –
CLOS
315
Compagnie Lombard Odier SCmA
Switzerland
$17K -$76.3K -1,200 -80%
WA
316
WFG Advisors
Texas
$17K -$57.2K -900 -75%
BKA
317
Brick & Kyle Associates
Pennsylvania
$17K – – –
FMII
318
Farmers & Merchants Investments Inc
Nebraska
$17K – – –
HI
319
Hudock Inc
Pennsylvania
$17K – – –
NSIM
320
North Star Investment Management
Illinois
$12K – – –
PSC
321
Prentiss Smith & Co
Vermont
$12K – – –
CTC
322
Central Trust Company
Missouri
$12K +$12.7K +200 New
SGC
323
South Georgia Capital
Illinois
$12K +$12.7K +200 New
TCM
324
Tradewinds Capital Management
Washington
$10K +$4.45K +70 +70%
AIM
325
Advantage Investment Management
Iowa
$9K – – –
11 12
13
14 15

IONS Hedge Fund Activity: Q2 2015 in Review

353 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2015, worth a combined $5.72B — down 11% from $6.45B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new IONS positions and 43 closed out — a net gain of 15 holders — while 112 added to existing stakes and 119 trimmed.

The largest buyer was Vanguard Group, adding an estimated $36.1M. The largest seller was BlackRock Fund Advisors, cutting an estimated $126M.

  • 353 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2015, up from 339 in Q1 2015.
  • Funds reported $5.72B of Ionis Pharmaceuticals stock for Q2 2015, down 11% quarter-over-quarter.
  • 58 funds opened new Ionis Pharmaceuticals positions in Q2 2015 and 43 closed out, a net change of +15 holders.
  • The largest Ionis Pharmaceuticals buyer in Q2 2015 was Vanguard Group, an estimated $36.1M added.
  • The largest Ionis Pharmaceuticals seller in Q2 2015 was BlackRock Fund Advisors, an estimated $126M sold.

Based on aggregated 13F filings for Q2 2015.